PuSH - Publikationsserver des Helmholtz Zentrums München

McCaw, Z.R.* ; O'Dushlaine, C.* ; Somineni, H.* ; Bereket, M.* ; Klein, C.* ; Karaletsos, T.* ; Casale, F.P. ; Koller, D.* ; Soare, T.W.*

An allelic-series rare-variant association test for candidate-gene discovery.

Am. J. Hum. Genet. 110, 1330-1342 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Allelic series are of candidate therapeutic interest because of the existence of a dose-response relationship between the functionality of a gene and the degree or severity of a phenotype. We define an allelic series as a collection of variants in which increasingly deleterious mutations lead to increasingly large phenotypic effects, and we have developed a gene-based rare-variant association test specifically targeted to identifying genes containing allelic series. Building on the well-known burden test and sequence kernel association test (SKAT), we specify a variety of association models covering different genetic architectures and integrate these into a Coding-Variant Allelic-Series Test (COAST). Through extensive simulations, we confirm that COAST maintains the type I error and improves the power when the pattern of coding-variant effect sizes increases monotonically with mutational severity. We applied COAST to identify allelic-series genes for four circulating-lipid traits and five cell-count traits among 145,735 subjects with available whole-exome sequencing data from the UK Biobank. Compared with optimal SKAT (SKAT-O), COAST identified 29% more Bonferroni-significant associations with circulating-lipid traits, on average, and 82% more with cell-count traits. All of the gene-trait associations identified by COAST have corroborating evidence either from rare-variant associations in the full cohort (Genebass, n = 400,000) or from common-variant associations in the GWAS Catalog. In addition to detecting many gene-trait associations present in Genebass by using only a fraction (36.9%) of the sample, COAST detects associations, such as that between ANGPTL4 and triglycerides, that are absent from Genebass but that have clear common-variant support.
Impact Factor
Scopus SNIP
Altmetric
9.800
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Allelic Series ; Gene-based Test ; Rare-variant Association Testing ; Target Identification ; Variant Pathogenicity ; Whole-exome Sequencing; Metaanalysis; Individuals; Framework; Angptl4; Disease; Traits; Lipids; Common; Risk
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 0002-9297
e-ISSN 1537-6605
Quellenangaben Band: 110, Heft: 8, Seiten: 1330-1342 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
Institut(e) Institute of AI for Health (AIH)
Helmholtz Pioneer Campus (HPC)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
Pioneer Campus
PSP-Element(e) G-540004-001
G-510000-001
Scopus ID 85166567866
PubMed ID 37494930
Erfassungsdatum 2023-10-06